Including continuous glucose monitors (CGMs) and insulin pumps in the next round of Medicare’s competitive bidding program ...
The Centers for Medicare & Medicaid Services has postponed its BALANCE pilot program for GLP‑1 obesity drug coverage until at least 2027 after insurers balked at costs and risks. In its place, CMS ...
Nearly three dozen states have signed onto a U.S. government initiative designed to help improve access to gene therapies that can eliminate serious symptoms of sickle cell disease, but remain ...
MMJ International Holdings Moves to Join Federal Lawsuit Challenging CMS Hemp-CBD Medicare Pilot as Preliminary Injunction ...
On May 28, 2025, the Centers for Medicare & Medicaid Services (“CMS”) Innovation Center formally announced the early termination of the Kidney Care First (“KCF”) model effective December 31, 2025, and ...
Major U.S. health insurers will standardize pre-treatment review requirements for certain medical services starting next year, aiming to reduce delays and denials. Meanwhile, the Trump ...
Federal Lawsuit Challenges CMS Hemp-CBD Medicare Pilot as Unlawful Policy Shortcut - MMJ International Holdings Says Case Exposes Regulatory Overreach That Undermines FDA Drug Approval Standards WASHI ...
The BEI program, launched April 1 through the CMS Innovation Center, allows participating healthcare organizations to discuss and furnish hemp-derived cannabinoid products containing no more than 0.3% ...
CHARLESTON, WV, UNITED STATES, January 12, 2026 /EINPresswire.com/ — The West Virginia Association of Health Plans (WVAHP) today formally introduced Medicaid Made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results